20 global teams will receive early-stage funding and access to [...]
Mainz Biomed has initiated a feasibility study as part of [...]
A new collaboration aims to tackle the toughest challenges in [...]
UK-based Alchemab Therapeutics has signed a landmark licensing agreement with [...]
PhaseV has secured $50 million in Series A funding to [...]